|
[1]TREBICKA J.Non-Cirrhotic portal hypertension:A possibly benign but complicated disease[J].Dig Liver Dis, 2018, 50 (8) :845-846.
|
|
[2]KHANNA R, SARIN SK.Non-cirrhotic portal hypertensiondiagnosis and management[J].J Hepatol, 2014, 60 (2) :421-441.
|
|
[3]VALLA DC, CAZALS-HATEM D.Vascular liver diseases on the clinical side:Definitions and diagnosis, new concepts[J].Virchows Arch, 2018, 473 (1) :3-13.
|
|
[4]GUIDO M, SARCOGNATO S, SACCHI D, et al.Pathology of idiopathic non-cirrhotic portal hypertension[J].Virchows Arch, 2018, 473 (1) :23-31.
|
|
[5]CHOUGULE A, RASTOGI A, MAIWALL R, et al.Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis[J].Hepatol Int, 2018, 12 (2) :158-166.
|
|
[6]KHANNA R, SARIN SK.Idiopathic portal hypertension and extrahepatic portal venous obstruction[J].Hepatol Int, 2018, 12 (Suppl 1) :148-167.
|
|
[7]GIOIA S, NARDELLI S, PASQUALE C, et al.Natural history of patients with non cirrhotic portal hypertension:Comparison with patients with compensated cirrhosis[J].Dig Liver Dis, 2018, 50 (8) :839-844
|
|
[8] WEHRMAN A, KRIEGERMEIER A, WEN J.Diagnosis and management of hepatobiliary complications in autosomal recessive polycystic kidney disease[J].Front Pediatr, 2017, 5:124.
|
|
[9]SOOD V, LAL BB, KHANNA R, et al.Noncirrhotic portal fibrosis in pediatric population[J].J Pediatr Gastroenterol Nutr, 2017, 64 (5) :748-753.
|
|
[10] European Association for the Study of the Liver.EASL Clinical Practice Guidelines:Vascular diseases of the liver[J].J Hepatol, 2016, 64 (1) :179-202.
|
|
[11]SARIN SK, KUMAR A, ANGUS PW, et al.Diagnosis and management of acute variceal bleeding:Asian Pacific Association for Study of the Liver recommendations[J].Hepatol Int, 2011, 5 (2) :607-624.
|
|
[12]MAURICE JB, BRODKIN E, ARNOLD F, et al.Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices[J].J Hepatol, 2016, 65 (5) :899-905.
|
|
[13]SIRAMOLPIWAT S, SEIJO S, MIQUEL R, et al.Idiopathic portal hypertension:Natural history and long-term outcome[J].Hepatology, 2014, 59 (6) :2276-2285.
|
|
[14]ETZION O, TAKYAR V, NOVACK V, et al.Spleen and liver volumetrics as surrogate markers of hepatic venous pressure gradient in patients with noncirrhotic portal hypertension[J].Hepatol Commun, 2018, 2 (8) :919-928.
|
|
[15]NORONHA FERREIRA C, SEIJO S, PLESSIER A, et al.Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis[J].Hepatology, 2016, 63 (5) :1640-1650.
|
|
[16]SHARMA P, AGARWAL R, DHAWAN S, et al.Transient elastography (Fibroscan) in patients with non-cirrhotic portal fibrosis[J].J Clin Exp Hepatol, 2017, 7 (3) :230-234.
|
|
[17]HAMIDAH NH, FARISAH NR, AZLINDA AB, et al.A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders[J].Clin Ter, 2012, 163 (2) :109-113.
|
|
[18]de FRANCHIS R, Baveno VI Faculty.Expanding consensus in portal hypertension report of the Baveno VI consensus workshop:Stratifying risk and individualizing care for portal hypertension[J].J Hepatol, 2015, 63 (3) :743-752.
|
|
[19]HASHMI K, AAMRI L, LAMKI S, et al.Portal vein thrombosis in adult omani patients:A retrospective cohort study[J].O-man Med J, 2017, 32 (6) :522-527.
|
|
[20]CHAWLA YK, BODH V.Portal vein thrombosis[J].J Clin Exp Hepatol, 2015, 5 (1) :22-40.
|
|
[21]RAJESH S, MUKUND A, SUREKA B, et al.Non-cirrhotic portal hypertension:An imaging review[J].Abdom Radiol (NY) , 2018, 43 (8) :1991-2010.
|
|
[22]VUPPALANCHI R, MATHUR K, PYKO M, et al.Liver stiffness measurements in patients with non-cirrhotic portal hypertension-the devil is in the details[J].Hepatology, 2018, 68 (6) :2438-2440.
|
|
[23]KHAN A, AYUB M, HAIDER I, et al.Coexisting giant splenic artery and portal vein aneurysms leading to non-cirrhoticportal hypertension:A case report[J].J Med Case Rep, 2016, 10 (1) :270.
|
|
[24]REGNAULT D, D'ALTEROCHE L, NICOLAS C, et al.Tenyear experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension[J].Eur J Gastroenterol Hepatol, 2018, 30 (5) :557-562.
|
|
[25]ZAMPINO R, LEBANO R, COPPOLA N, et al.The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients[J].Saudi J Gastroenterol, 2018, 24 (1) :25-29.
|
|
[26]SORENSEN M, LARSEN LP, VILLADSEN GE, et al.β-Blockers improve presinusoidal portal hypertension[J].Dig Dis Sci, 2018.[Epub ahead of print]
|
|
[27]SPAANDER MC, DARWISH MURAD S, van BUUREN HR, et al.Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis:A long-term follow-up study[J].Gastrointest Endosc, 2008, 67 (6) :821-827.
|
DownLoad: